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Pu
ReThe practice of medicine continues to evolve, and individual circumstances will vary. This publication reflects information
available at the time of its submission for publication and is neither designed nor intended to establish an exclusive standard of
perinatal care. This publication is not expected to reflect the opinions of allmembers of the Society forMaternal-FetalMedicine.rrespondin
blications C
ceived AprPreterm birth remains a major cause of neonatal death and short and long-term disability in the US and
across the world. The majority of preterm births are spontaneous and cervical length screening is one
tool that can be utilized to identify women at increased risk who may be candidates for preventive in-
terventions. The purpose of this document is to review the indications and rationale for cervical length
screening to prevent preterm birth in various clinical scenarios. The Society for Maternal-Fetal Medicine
recommends (1) routine transvaginal cervical length screening for women with singleton pregnancy and
history of prior spontaneous preterm birth (GRADE 1A); (2) routine transvaginal cervical length screening
not be performed for women with cervical cerclage, multiple gestation, preterm premature rupture of
membranes, or placenta previa (GRADE 2B); (3) practitioners who decide to implement universal cervical
length screening follow strict guidelines (GRADE 2B); (4) sonographers and/or practitioners receive
specific training in the acquisition and interpretation of cervical imaging during pregnancy (GRADE 2B).
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spontaneous preterm birth, transvaginal ultrasoundorldwide, fifteen million babies are born too soon researchers and clinicians have studied a variety of factorsWevery year, causing 1.1 million deaths, as well as
short- and long-term disability in countless survivors.1 The
majority (two thirds) of preterm births (PTB) are sponta-
neous, and recurrence risks are high; a history of a prior
spontaneous PTB is historically the strongest risk factor for
spontaneous PTB. Few prognostic tests are available to
predict which pregnancies will deliver preterm; transvaginal
cervical length (CL) measurement is an important clinical
tool to identify women at high risk for PTB in order to allow
for interventions to prevent, delay, or prepare for PTB. The
purpose of this document is to review the currently
accepted indications for CL length screening to prevent
PTB in various common clinical scenarios.What is the clinical significance of a
sonographically short cervix?
Womenwith a history of a prior spontaneousPTBaccount for
only 10% of all births < 34 weeks of gestation.2,3 Thus,g author: The Society for Maternal-Fetal Medicine: 
ommittee. pubs@smfm.org
il 5, 2016; accepted April 19, 2016.separate from past pregnancy history in order to further risk-
stratifywomenandattempt to identify thoseathighest risk for
PTB. Currently, mid-trimester CL assessment by trans-
vaginal ultrasound is the best clinical predictor of sponta-
neous PTB.4 Depending on the population studied and the
gestational age of assessment, the threshold chosen in
clinical practice as “short” ranges from 20 to 30 mm.
The risk of spontaneous PTB is inversely proportional to
the length of the cervix; those with the shortest CL have the
highest risk of prematurity. In one study of unselected
pregnant women 22-24weeks of gestation, only 1.7%had a
CL<15mm, but they accounted for 86% of PTB<28 weeks
of gestation and 58% of PTB less than 32 weeks of gesta-
tion.5 The specificity of a short CL is related to the cutoff
used; in one study (including both high- risk and low-risk
women), the specificity was 99.9% (95% CI 99.8-100.0%)
for PTB < 34 weeks of gestation for a CL  20mm; this
decreased to 90.1% (95%CI 89.0-91.2%) for a CL 30mm,
and fell further to 65.5% (95% CI 63.8-67.3%) for CL
35 mm.6 The finding of a short CL, irrespective of prior
pregnancy history, has been consistently and reproducibly
associatedwith an elevated risk of spontaneous PTBacross
BOX 1
Steps for proper cervical length measurementdifferent gestational age cutoffs and multiple patient pop-
ulations. In addition, women with a history of a prior spon-
taneous PTB and a short CL are at the highest risk.7(1) Ensure patient has emptied her bladder.
(2) Prepare the cleaned probe using a probe cover.
(3) Gently insert the probe into the patient’s vagina.Should the cervical length be evaluated by
transabdominal or transvaginal ultrasound?(4) Guide the probe into the anterior fornix.
(5) Obtain a sagittal, long-axis image of the entire cervix.
(6) Remove the probe until the image blurs and then reinsert
gently until the image clears (this ensures you are not using
excessive pressure).
(7) Enlarge the image so that the cervix occupies two thirds of the
screen.
(8) Ensure both the internal and external os are seen clearly.
(9) Measure the cervical length along the endocervical canal
between the internal and external os.
(10) Repeat this process twice to obtain 3 sets of images/
measurements.
(11) Use the shortest best measurement.
Cervical Length Education and Review (www.perinatalquality.org/CLEAR), a program of
training and certification, is offered through the Perinatal Quality Foundation.
SMFM. Role of routine cervical length screening for preterm birth prevention. Am J
Obstet Gynecol 2016.Transvaginal ultrasound is considered the ‘gold standard’
measurement when assessing CL. In contrast to
transabdominal ultrasound, transvaginal ultrasound mea-
surements are highly reproducible, and measurements are
unaffected by maternal obesity, cervical position, and
shadowing from fetal parts.8-11
Transvaginal ultrasound is also more sensitive than
transabdominal ultrasound using CL cutoffs typically used
to screen for a short cervix.12 For example, the sensitivity
using transabdominal ultrasound to identify a (confirmed by
transvaginal ultrasound) short cervix <25 mm ranges from
44.7% (using a transabdominal cutoff of 25mm) to 96.1%
(using a transabdominal cutoff of 36mm).12,13 Transvaginal
ultrasound is safe, and when performed by trained opera-
tors results are reproducible with a relatively low inter-
observer variation rate of 5-10%.14,15What steps should be performed to
accurately evaluate the cervical length?
With the woman’s bladder emptied, the vaginal transducer
should be inserted into the anterior fornix of the vagina and
positioned so that the endocervical canal is visualized. The
ultrasound probe should be gradually withdrawn until the
image is just visible to ensure there is not excessive pres-
sure on the probe. A minimum of 3 CL measurements
should be obtained by placing calipers at the internal and
external os. The shortest, best measurement should be
recorded.16-18 (Box 1)
Ideally, measurements should be obtained by sonogra-
phers and/or practitioners who have received specific
training in the acquisition and interpretation of cervical im-
aging during pregnancy in order to avoid improper mea-
surement. As part of a multicenter RCT involving CL
measurement conducted by the Eunice Kennedy Shriver
NICHD MFMU Network, a quality control study was per-
formed. In this analysis, one in four CL ultrasound images
initially submitted for certification by investigators at the
participating centers did not meet published quality
criteria.19 Improper measurement (caliper placement and/or
failure to identify the shortest best image) and failure to
obtain a satisfactory image (excessive compression,
required landmark not visible, incorrect image size, brief
examination and/or full maternal bladder) were the major
reasons for deficient cervical images. Thus, similar to
assessment of nuchal translucency with first trimester
screening,20 improper measurement of the cervix may lead
to impaired performance of CL as a screening test.
Several training programs are available online, including
the Cervical Length Education and Review (CLEAR)
program (sponsored by SMFM and its Perinatal QualityFoundation, available at https://clear.perinatalquality.org),
and the Fetal Medicine Foundation’s Certificate of
Competence in cervical assessment (available at https://
fetalmedicine.org). We recommend sonographers and/or prac-
titioners receive specific training in the acquisition and interpre-
tation of cervical imaging during pregnancy. (GRADE 2B)If the cervical length is assessed by
ultrasound, when during pregnancy
should it be evaluated?
If transvaginal CL screening is performed, the cervix should
be assessed between 16 and 24 weeks gestation. It should
not be routinely measured prior to 16 weeks of gestation.21
Prior to this time, the lower uterine segment is underdevel-
oped, making it challenging to distinguish this area from the
endocervical canal. In fact studies evaluating first and early
second trimester CL had not consistently shown adequate
predictive value of CL measurement for preterm birth.22-25
RoutineCL screening is also not advised beyond24weeks
of gestation in asymptomatic women, because studies of
interventions (e.g., cerclage, vaginal progesterone) have
most often used 24 weeks of gestation as the upper gesta-
tional age limit for screening and initiation of therapies or
interventions. CL screening after 24 weeks of gestation in
asymptomatic women provides limited clinical value and
there is absence of data to suggest it improves outcomes.How should the approach to cervical length
screening differ for womenwith andwithout a
prior preterm birth?
The approach to CL screening varies based on patient
characteristics and risk factors. Current SMFM and
American College of Obstetricians and Gynecologists
(ACOG) guidelines recommend women with a prior
spontaneous PTB undergo CL screening with transvaginal 
ultrasound.10,11 Serial assessment of CL is usually per-
formed (every 1-2 weeks as determined by the clinical sit-
uation) from 16 until 24 weeks of gestation. We recommend 
routine transvaginal CL screening for women with singleton 
pregnancy and history of prior spontaneous PTB. (GRADE 1A)
The issue of universal transvaginal ultrasound CL screening 
of singleton gestations without prior PTB for the prevention of 
PTB remains an object of debate.26,27 Current SMFM 
guidelines state CL screening in singleton gestations without 
prior PTB cannot yet be universally mandated. Nonetheless, 
implementation of such a screening strategy can be viewed 
as reasonable, and can be considered by individual practi-
tioners. Given the impact on prenatal care and potential 
misuse of universal screening, stretching the criteria and 
management beyond those tested in RCTs should be pre-
vented. Practitioners who decide to implement universal CL 
screening should follow strict guidelines (GRADE 2B).10,11
Data regarding real-world implementation of CL 
screening programs are evolving.28-30 Ozechowski and 
colleagues published their experience with universal cervi-
cal length screening at a single institution.28 Over an
18-month period, 1,569 women (72.3% of eligible) under-
went transvaginal ultrasound screening and 1.1% of those 
without a prior spontaneous PTB has a cervix  20 mm. Son 
and colleagues published their implementation experience 
comparing PTB rates before and after introduction of a 
formal program of universal cervical screening.29 After 
implementation, of the 17,590 women (99.9% of eligible) 
0.89% had CL  25 mm. Introduction of the program was 
associated with a significant decrease in PTB < 37 wks 
(6.7% vs. 6.0%; adjusted OR 0.82 [95% CI 0.76-0.88]) and 
< 34 wks (1.9% vs. 1.7%; adjusted OR 0.74 [95% CI 0.64-
0.85]). Finally, Temming and colleagues did CL screening for 
10,871 women with a singleton pregnancy undergoing 
midtrimester anatomy survey (85% of eligible) and found 
2% with cervix  25 mm and 1.2% cervix  20 mm.30Other special situations
Should women with a history of treatment for 
cervical dysplasia (in the absence of a prior 
preterm birth) undergo routine serial cervical 
length screening?
There is insufficient evidence to support additional 
screening for women with a previous electrosurgical pro-
cedure (loop electrical excision procedure, LEEP) or cold 
knife cone for cervical dysplasia.
A recent large retrospective cohort study, as well as 
a systematic review and meta- analysis, found that 
while average CL is shorter in women after a procedure, 
most nevertheless have a normal mid-trimester CL and 
more importantly, the increased risk of spontaneous PTB 
in this population appears related to the history of 
cervical dysplasia, not the procedure itself.31-32 
Therefore, these otherwise low-risk women who have 
undergone treatmentfor cervical dysplasia or have a history of dysplasia do not
require additional evaluation beyond that which would
routinely beoffered towomenwithout ahistoryof a priorPTB.
Should women undergo routine cervical length
screening after cerclage placement?
Several small studies evaluated this question in all types
of cerclage (history-indicated, ultrasound-indicated, and
physical exam-indicated).33-44 These results demonstrated
that progressive cervical shortening after cerclage
increases the risk of PTB,33-35,38 particularly if CL is
<10mm,43,44 but neither overall CL nor length below the
stitch correlate well with outcomes,35,36,39-41 and, impor-
tantly, there are currently no additional treatment options for
a short cervix after cerclage (e.g. reinforcement suture does
not improve outcomes).34-37 Although there may be theo-
retical psychological benefit to the patient and provider to
visualize the stitch location post-procedure, there are
insufficient data to suggest a clinical benefit of routine post-
cerclage CL measurement or surveillance.
Should women with multiple gestations undergo
routine cervical length screening?
In women with multiple pregnancies, the cervix is shorter and
associated with an increased risk of PTB.45,46 In the large,
multicenter Preterm Prediction Study conducted by the
MFMUNetwork, approximately 18% of twin gestations had a
CL <25mm at 22-24 weeks of gestation (compared to 9% of
singletons).47The riskofPTBwithaCL<25mmwas increased
8-fold in twins, compared to 6-fold in singletons.18,47
Various interventions (e.g. progesterone, pessary) are
currently being tested in RCT’s for women with multiple
gestation and shortened cervix, but at this time available
data does not indicate adequate clinical benefit to justify
routine screening of all womenwithmultiple gestations.48-50
For this reason, routine CL screening in multiple pregnan-
cies is not currently recommended by SMFM.11What is the role of cervical length screening
to predict preterm birth for women in other
clinical scenarios?
Threatened preterm labor
Transvaginal ultrasound CL measurement may serve as an
adjunct to digital cervical examination in the assessment of
women with symptoms of acute PTL.51-53 Several obser-
vational studies have noted that the combination of CL and
fetal fibronectin (FFN) assessment may improve prediction
of PTB among women with symptoms of acute preterm
labor.54-56 In triage units that combine CL screening and
FFN testing in “symptomatic” patients, FFN does not add to
PTB prediction in women with a very short (<20mm) or long
(>30 mm) CL. In these situations FFN may be discarded
because the NPV of CL  30 mm alone is high (96-100%)
and women with CL <20 mm are at high enough risk that
PTL treatment should be initiated based on CL alone.54
Clinical guidelines from professional societies
that address CL screening or CL assessment
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The recommendations in this document reflect the national and international guidelines
related to the cervical length screening for preterm birth prevention.
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SMFM. Role of routine cervical length screening for preterm birth prevention. Am J
Obstet Gynecol 2016.When used in combination with CL screening, FFN may be
most useful in women with CL of 20-29 mm (e.g. the “grey
zone”); in this situation a “negative test” (z80% of cases)
may allow for no treatment while a positive test would
suggest the need for intervention (antenatal corticosteroids,
transfer to tertiary center, etc).54-56 There remains some
controversy with the routine use of FFN with or without CL
screening to detect true PTL in symptomatic women. To
date, only one interventional trial has shown that knowledge
of CL and FFN improves outcomes. In 2007 Ness and col-
leagues published results of their single center RCT that
involved 100 women who were being evaluated for threat-
enedPTL. KnowledgeofCL andFFN resultswas associated
with a shorter duration of assessment in women with CL 
30mmand overall a lower rate of SPTB (13%vs. 36.2%; p¼
0.01).55 However, a recent systematic review involving
women being assessed for PTL utilizing FFN without CL
screening did not show any clinical improvements.57
Preterm premature rupture of membranes
Prospective studies incorporating nearly 500 women total
with PPROM are conflicting; 4 studies found shorter CLs to
be associated with shorter latencies,58-61 but a fifth study
did not.62 The latter study, however, was specifically pow-
ered to establish the safety of weekly CL measurements in
the setting of PPROM, and found a similar incidence of
chorioamnionitis among those in the no-probe and probe
groups (28% versus 20%). The incidence of endometritis
(6% versus 9%) and neonatal infection (17% versus 20%)
were also similar between groups.62
A prospective observational cohort of 105 women with
PPROM between 23-33 weeks of gestation found that 40%
of women had a transvaginal CL <2cm, and the positive
predictive value of delivery within 7 days was 62%.61
Although CL measurement does not appear to causeharmwith PPROMand a shortened cervix is associatedwith
shorter latency, there are insufficient data to suggest a
clinical benefit to CL measurement or surveillance.
Placenta previa
Three prospective studies, which included a total of
approximately 185 women combined, evaluated the utility
of CL in the third trimester as a predictor for emergency
cesarean delivery and hemorrhage in women with
previa.63-65 All studies used a CL cutoff of 30mm to define
the cervix as ‘short,’ and reported that those with a short CL
weremore likely to have hemorrhage and emergent delivery.
The largest study found that of 68 women with placenta
previa, 29 had a transvaginal ultrasound CL <30mm; of
 
 
these, 79% delivered prematurely due to hemorrhage, 
compared to 28% of women with a CL 30mm.65
Whereas these three studies demonstrate that there may 
be an association between shortened CL and PTB in the 
setting of placenta previa, there are no prospective studies 
testing a management strategy based on CL, and there are 
insufficient data to suggest a proven clinical benefit of
routine CL measurement or surveillance. We recommend 
routine transvaginal CL screening not be performed for women 
with cervical cerclage, multiple gestation, PPROM, or placenta
previa. (GRADE 2B) 
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